Jason Mendy

552 total citations
14 papers, 256 citations indexed

About

Jason Mendy is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Epidemiology. According to data from OpenAlex, Jason Mendy has authored 14 papers receiving a total of 256 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 9 papers in Public Health, Environmental and Occupational Health and 6 papers in Epidemiology. Recurrent topics in Jason Mendy's work include Mosquito-borne diseases and control (9 papers), Viral Infections and Vectors (7 papers) and Viral Infections and Outbreaks Research (5 papers). Jason Mendy is often cited by papers focused on Mosquito-borne diseases and control (9 papers), Viral Infections and Vectors (7 papers) and Viral Infections and Outbreaks Research (5 papers). Jason Mendy collaborates with scholars based in United States, Russia and Ireland. Jason Mendy's co-authors include Jeff Alexander, Darly J. Manayani, Lo Vang, Fermin Garduño, Jenny B. Avanzini, Peggy Farness, Lisa Bedell, Jason S. Richardson, Jonathan D. Smith and Lisa M. Higgins and has published in prestigious journals such as The Lancet, PLoS ONE and The Lancet Infectious Diseases.

In The Last Decade

Jason Mendy

14 papers receiving 246 citations

Peers

Jason Mendy

PHEOH

IMMUN

EPIDE

Jane Ennis United States

Lo Vang United States

Andrey V. Barkhash Russia

Colleen Tingey United States

Hui Hui Wong Singapore

Yong-Dae Gwon Sweden

Maria D. Gainey United States

Nicole Corre-Catelin France

Robert Blouch United States

Kathryn M. Frietze United States

Jane Ennis United States

Jason Mendy

184 ×1.4

97 ×0.8

PHEOH

61 ×0.8

IMMUN

68 ×0.9

EPIDE

48 ×1.0

Citations per year, relative to Jason Mendy Jason Mendy (= 1×) peers Jane Ennis

Countries citing papers authored by Jason Mendy

Since Specialization

Citations

This map shows the geographic impact of Jason Mendy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason Mendy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason Mendy more than expected).

Fields of papers citing papers by Jason Mendy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason Mendy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason Mendy. The network helps show where Jason Mendy may publish in the future.

Co-authorship network of co-authors of Jason Mendy

This figure shows the co-authorship network connecting the top 25 collaborators of Jason Mendy. A scholar is included among the top collaborators of Jason Mendy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason Mendy. Jason Mendy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

McCarty, James, Jason A. Regules, Jason Mendy, et al.. (2025). Safety and immunogenicity of an adjuvanted chikungunya virus virus-like particle (CHIKV VLP) vaccine in previous recipients of other alphavirus vaccines versus alphavirus vaccine-naive controls: an open-label, parallel-group, age-matched, sex-matched, phase 2 randomised controlled study. The Lancet Microbe. 6(4). 101000–101000. 2 indexed citations

Tindale, Lauren C., Jason S. Richardson, Deborah M. Anderson, et al.. (2025). Chikungunya virus virus-like particle vaccine safety and immunogenicity in adults older than 65 years: a phase 3, randomised, double-blind, placebo-controlled trial. The Lancet. 405(10487). 1353–1361. 10 indexed citations

Richardson, Jason S., Deborah M. Anderson, Jason Mendy, et al.. (2025). Chikungunya virus virus-like particle vaccine safety and immunogenicity in adolescents and adults in the USA: a phase 3, randomised, double-blind, placebo-controlled trial. The Lancet. 405(10487). 1343–1352. 7 indexed citations

Beaty, Shannon M., Nicos Karasavvas, Robert A. Kuschner, et al.. (2023). A Phase 1 Two-Arm, Randomized, Double-Blind, Active-Controlled Study of Live, Oral Plasmid-Derived Adenovirus Type 4 and Type 7 Vaccines in Seronegative Adults. Vaccines. 11(6). 1091–1091. 1 indexed citations

Richardson, Jason S., et al.. (2023). 2888. Safety and Immunogenicity of an Adjuvanted Chikungunya Virus (CHIKV) Virus-like Particle (VLP) Based Vaccine in Two Pivotal Phase 3 Trials, ≥12 Years of Age. Open Forum Infectious Diseases. 10(Supplement_2). 3 indexed citations

McCarty, James, Lisa Bedell, Jason Mendy, et al.. (2023). Chikungunya virus virus-like particle vaccine is well tolerated and immunogenic in chikungunya seropositive individuals. Vaccine. 41(42). 6146–6149. 4 indexed citations

Thompson, Danielle, Darly J. Manayani, Jason Mendy, et al.. (2022). Zika virus-like particle vaccine fusion loop mutation increases production yield but fails to protect AG129 mice against Zika virus challenge. PLoS neglected tropical diseases. 16(7). e0010588–e0010588. 4 indexed citations

Bennett, Sean, James McCarty, Roshan Ramanathan, et al.. (2022). Safety and immunogenicity of PXVX0317, an aluminium hydroxide-adjuvanted chikungunya virus-like particle vaccine: a randomised, double-blind, parallel-group, phase 2 trial. The Lancet Infectious Diseases. 22(9). 1343–1355. 42 indexed citations

Vang, Lo, Christopher S. Morello, Jason Mendy, et al.. (2021). Zika virus-like particle vaccine protects AG129 mice and rhesus macaques against Zika virus. PLoS neglected tropical diseases. 15(3). e0009195–e0009195. 19 indexed citations

10.

Espinosa, Diego A., Jason Mendy, Darly J. Manayani, et al.. (2017). Passive Transfer of Immune Sera Induced by a Zika Virus-Like Particle Vaccine Protects AG129 Mice Against Lethal Zika Virus Challenge. EBioMedicine. 27. 61–70. 42 indexed citations

11.

Alexander, Jeff, Jason Mendy, Lo Vang, et al.. (2013). Pre-Clinical Development of a Recombinant, Replication-Competent Adenovirus Serotype 4 Vector Vaccine Expressing HIV-1 Envelope 1086 Clade C. PLoS ONE. 8(12). e82380–e82380. 18 indexed citations

12.

Alexander, Jeff, Simone Visosky Ward, Jason Mendy, et al.. (2012). Pre-Clinical Evaluation of a Replication-Competent Recombinant Adenovirus Serotype 4 Vaccine Expressing Influenza H5 Hemagglutinin. PLoS ONE. 7(2). e31177–e31177. 44 indexed citations

13.

Alexander, Jeff, Marc Gurwith, Jason Mendy, et al.. (2012). Development of a HIV-1 vaccine using an orally-administered, replication-competent adenovirus serotype 4 vector expressing Env clade C glycoprotein. Retrovirology. 9(S2). 1 indexed citations

14.

Lo, David, Jason Mendy, Daragh Byrne, et al.. (2003). Peptidoglycan recognition protein expression in mouse Peyer’s Patch follicle associated epithelium suggests functional specialization. Cellular Immunology. 224(1). 8–16. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact